CAY10506 – 1 mg

Brand:
Cayman
CAS:
292615-75-9
Storage:
-20
UN-No:
De Minimis - 1231 / 3

Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 µM.{14244}  

 

Available on backorder

SKU: 10009079 - 1 mg Category:

Description

A hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 µM


Formal name: N-[2-[4-[(2,4-dioxo-5-thiazolidinyl)methyl]phenoxy]ethyl]-1,2-dithiolane-3-pentanamide

Synonyms: 

Molecular weight: 454.6

CAS: 292615-75-9

Purity: ≥98%

Formulation: A solution in methyl acetate


Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs